Please Wait

Applying Filters...

Looking for CAS-62-31-7? Find Controlled & Modified Release used in CAS-62-31-7 to address drug delivery challenges on PharmaCompass.

CAS-62-31-7

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 7 USDMF, 2 CEP/COS, 5 JDMF, 1 KDMF, 1 NDC API, 7 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 52 FDA Orange Book, 8 Europe, 3 Canada, 3 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/100ML, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/100ML

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl, 6 Actylis, 1 Gangwal Chemicals, 1 Kerry, 1 Pluviaendo, 4 Roquette

EXCIPIENTS BY APPLICATIONS

7 Parenteral, 3 Controlled & Modified Release, 3 Coating Systems & Additives, 2 Fillers, Diluents & Binders, 2 Thickeners and Stabilizers, 2 Taste Masking, 1 Film Formers & Plasticizers, 1 Topical

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

12 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 6 Others

$ Xls

Filters

CAS-62-31-7

Filters

FILTER :

filter Company Reset all filters

5 All

01 4Actylis

02 1Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Kerry

SHEFFCOAT™ CG

CPhI India 2024

Not Confirmed

02

Actylis

SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

CPhI India 2024

Not Confirmed

03

Actylis

SODIUM CITRATE DIHYDRATE USP-NF

CPhI India 2024

Not Confirmed